PRISTIQ® (desvenlafaxine) is approved for the treatment of major depressive disorder in adults.
Suicidality and Antidepressant Drugs
Antidepressants increased the risk compared to placebo of suicidal thinking and behavior (suicidality) in children, teens, and young adults. Depression and certain other psychiatric disorders are themselves associated with increases in the risk of suicide. Patients of all ages who are started on antidepressant therapy should be monitored appropriately and observed closely for clinical worsening, suicidality, or unusual changes in behavior. PRISTIQ is not approved for use in children under 18.
The Wyeth Pharmaceutical Assistance Foundation provides Wyeth products at no cost to low-income, uninsured patients. Click here to learn more about the Patient Assistance Program.
Hope this help